Journal articleWorld J Gastrointest Oncol2017
Neoadjuvant therapy for resectable pancreatic cancer.
- Journal
- World J Gastrointest Oncol
- Published
- 1 December 2017
- Citations
- 15
- Type
- Article
- License
- cc by-nc
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract cc by-nc
The use of neoadjuvant therapies has played a major role for borderline resectable and locally advanced pancreatic cancers (PCs). For this group of patients, preoperative chemotherapy or chemoradiation has increased the likelihood of surgery with negative resection margins and overall survival. … Excerpt only: this text is the publisher’s. Read it in full at the source.